Clinical trial
Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder
NCT01972074 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 17, 2015
- Completion date
- May 7, 2018
- Enrollment
- 84 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.